These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 28042340)

  • 21. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
    Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
    Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. pH-responsive polydopamine nanoparticles for photothermally promoted gene delivery.
    Zhang P; Xu Q; Li X; Wang Y
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110396. PubMed ID: 31924025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy.
    Liu H; Liu C; Ye L; Ma D; He X; Tang Q; Zhao X; Zou H; Chen X; Liu P
    Adv Mater; 2021 Feb; 33(7):e2003523. PubMed ID: 33354783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
    Sadhukhan P; Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():129-140. PubMed ID: 30948047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.
    Ewe A; Höbel S; Heine C; Merz L; Kallendrusch S; Bechmann I; Merz F; Franke H; Aigner A
    Drug Deliv Transl Res; 2017 Apr; 7(2):206-216. PubMed ID: 27334279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tailored design of multifunctional and programmable pH-responsive self-assembling polypeptides as drug delivery nanocarrier for cancer therapy.
    Wang TW; Yeh CW; Kuan CH; Wang LW; Chen LH; Wu HC; Sun JS
    Acta Biomater; 2017 Aug; 58():54-66. PubMed ID: 28606810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-responsive and targeted delivery of curcumin via phenylboronic acid-functionalized ZnO nanoparticles for breast cancer therapy.
    Kundu M; Sadhukhan P; Ghosh N; Chatterjee S; Manna P; Das J; Sil PC
    J Adv Res; 2019 Jul; 18():161-172. PubMed ID: 31032117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.
    Mok H; Veiseh O; Fang C; Kievit FM; Wang FY; Park JO; Zhang M
    Mol Pharm; 2010 Dec; 7(6):1930-9. PubMed ID: 20722417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic siRNA delivery to a spontaneous pancreatic tumor model in transgenic mice by PEGylated calcium phosphate hybrid micelles.
    Pittella F; Cabral H; Maeda Y; Mi P; Watanabe S; Takemoto H; Kim HJ; Nishiyama N; Miyata K; Kataoka K
    J Control Release; 2014 Mar; 178():18-24. PubMed ID: 24440662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery
    Zhu X; Tao W; Liu D; Wu J; Guo Z; Ji X; Bharwani Z; Zhao L; Zhao X; Farokhzad OC; Shi J
    Theranostics; 2017; 7(7):1990-2002. PubMed ID: 28638484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
    Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
    Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
    Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
    J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer.
    Halbur C; Choudhury N; Chen M; Kim JH; Chung EJ
    SLAS Technol; 2019 Apr; 24(2):137-150. PubMed ID: 30616494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery.
    Yang XZ; Du JZ; Dou S; Mao CQ; Long HY; Wang J
    ACS Nano; 2012 Jan; 6(1):771-81. PubMed ID: 22136582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticles.
    Feng Q; Yu MZ; Wang JC; Hou WJ; Gao LY; Ma XF; Pei XW; Niu YJ; Liu XY; Qiu C; Pang WH; Du LL; Zhang Q
    Biomaterials; 2014 Jun; 35(18):5028-38. PubMed ID: 24680191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
    He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
    Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.